Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Therapeutic area

Renal and urinary disorders – page 24

  • 591 clinical trials
  • 223 recruiting
  • 296 conditions
  • 27 countries

Conditions in this area

296 conditions with trials, the busiest first

Chronic kidney disease64Bladder cancer55Transitional cell carcinoma47Renal cell carcinoma42Bladder transitional cell carcinoma34IgA nephropathy24Acute kidney injury21Non-small cell lung cancer19Urinary tract infection19Lupus nephritis18Clear cell renal cell carcinoma17Paroxysmal nocturnal haemoglobinuria17Breast cancer14Metastatic renal cell carcinoma14End stage renal disease13Congenital cystic kidney disease12Colorectal cancer11Endometrial cancer11Hepatocellular carcinoma11Malignant melanoma11Nephrotic syndrome11Ovarian cancer11Glomerulonephritis membranous10Kidney transplant rejection10+272

Clinical trials in Renal and urinary disorders

591 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

591 clinical trials

Glomerulonephritis membranous

Not yet recruiting

Study of obinutuzumab to reduce PLA2R antibodies in patients with primary membranous nephropathy

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Obinutuzumab
  • Sponsor:Stichting Radboud universitair medisch centrum

Acute kidney injury

Not yet recruiting

Study comparing effects of propofol and sevoflurane on kidney blood flow using magnetic resonance imaging in children at risk of post-operative kidney injury

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Propofol
  • Sponsor:Region Uppsala

Chronic kidney disease

Not yet recruiting

Study of eplerenone in patients with heart failure and reduced ejection fraction who also have severe chronic kidney disease

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Altizide
  • Sponsor:Karolinska Institutet

Bladder cancer

Not yet recruiting

Study of Sacituzumab Govitecan and Zimberelimab for Muscle-Invasive Bladder Cancer in Patients Unable to Take Cisplatin or Unwilling to Have Surgery

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Zimberelimab
  • Sponsor:Fondazione IRCCS Istituto Nazionale Dei Tumori

Chronic prostatitis/chronic pelvic pain syndrome

Not yet recruiting

Study on Botulinum Toxin Type A for Adults with Chronic Pelvic Pain Syndrome (CPPS)

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Botulinum Toxin Type A
  • Sponsor:Ospedale San Raffaele S.r.l.

Hypercalciuria

Not yet recruiting

Study on Vitamin D Supplementation (Colecalciferol) and Its Effect on Urinary Calcium Levels in Children and Teens Aged 2 to 18 Years

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Substances:Colecalciferol
  • Sponsor:Centre Hospitalier Universitaire De Montpellier

Chronic kidney disease

Not yet recruiting

Study of Sevuparin for Patients with Chronic Kidney Disease

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Sevuparin
  • Sponsor:Modus Therapeutics AB

Diabetic nephropathy+2

Not yet recruiting

Study on Aspirin's Effect on Platelet Aggregation in Patients with Type 1 Diabetes, Atherosclerotic Cardiovascular Disease, and Diabetic Kidney Disease

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Acetylsalicylic Acid
  • Sponsor:Steno Diabetes Center Copenhagen

Acute kidney injury

Not yet recruiting

Study on Nicotinamide for Patients with Acute Kidney Injury

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Nicotinamide
  • Sponsor:Centre Hospitalier Regional De Marseille

Abdominal infection+5

Not yet recruiting

Study on Aztreonam, Avibactam, and Metronidazole for Treating Infections in Neonates and Infants Under 9 Months with Gram-Negative Bacterial Infections

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:0–17 years
  • Substances:Avibactam Sodium
  • Sponsor:Pfizer Inc.

Polyomavirus-associated nephropathy

Not yet recruiting

Study on the Safety and Effectiveness of Tacrolimus and Drug Combination for Patients with BK Polyomavirus Infection After Kidney Transplantation

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Azathioprine

Hepatocellular carcinoma+5

Not yet recruiting

Study on the Safety and Effectiveness of CEB-01 for Children with Resectable Tumors

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:7-Ethyl-10-Hydroxycamptothecin
  • Sponsor:Cebiotex S.L.

Substances studied in this area

The therapies tested most often in Renal and urinary disorders trials.

Pembrolizumab54 clinical trialsNivolumab36 clinical trialsDapagliflozin25 clinical trialsMycophenolate Mofetil24 clinical trialsCabozantinib22 clinical trialsCisplatin22 clinical trialsIpilimumab21 clinical trialsGemcitabine20 clinical trialsSodium Chloride17 clinical trials
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.